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poor conditions that cause normal cells
to arrest. The finding that cells lacking
a functional p53 continue to proliferate
under such conditions might be one
more reason behind the frequency of
p53 loss in human cancers. It may also
explain how the loss of AMPK and LKB1
can promote tumorigenesis.
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Super-size flies
The increasing prevalence of obesity and other nutrition-related chronic diseases has prompted considerable efforts to
understand their pathogenesis and treatment. One experimental approach is to overexpress, inactivate, or manipulate
specific genes that regulate energy metabolism and fat storage. Many such techniques are fully established, routine tools
in Drosophila and C. elegans, which provide elegant models for dissecting endocrine problems and metabolic pathways.In the past decade, obesity has been d
recognized as an increasing threat to a
mglobal health, with numerous associated
life-threatening complications, including e288iabetes, heart disease, hypertension, e
ind cancer (Flegal et al., 2002; Kopel-
an, 2000). To maintain constant weight, a
(nergy intake (food eaten) must equalnergy consumed (by metabolism). Any
mbalance is reflected in a change in the
mount of stored energy, mainly as fat
Figure 1). Fat in the form of triacylglyc-CELL METABOLISM : MAY 2005
P R E V I E Werols (TAG) is found in intracellular neu-
tral lipid droplets that occupy the major
volume of adipocytes but are also pres-
ent in virtually all cell types. Regulation
of fat depots involves a complex in-
terplay between central regulators of
feeding behavior in the nervous system,
neuroendocrine signals, and metabolic
regulators of energy expenditure and fat
storage (Flier, 2004). Genetic analysis
has the potential to identify new players
in these processes, each of which in
turn represents a potential target for pre-
vention or treatment of obesity and its
medical consequences. In this issue of
Cell Metabolism, Grönke and colleagues
employ a genetic strategy to identify
such a candidate from the fruit fly Dro-
F
sophila: brummer, which encodes a tria-
cylglycerol lipase (Grönke et al., 2005;
t[this issue of Cell Metabolism]).
oOur current understanding of the mo-
lecular mechanisms underlying fat stor-
page and utilization derives largely from
fstudies in cultured mammalian adipo-
tcytes. Studies of transgenic and knock-
oout mice have also advanced our un-
bderstanding of the regulation of food
fconsumption, body composition, and
jmetabolic rate (Friedman, 2003; Flier,
i2004; O’Rahilly et al., 2003). Although
fgenetics has been applied successfully in
cmammalian model systems, only a small
sfraction of the genes influencing obesity
shave so far been identified (Barsh and
pSchwartz, 2002). Among the most conse-
tquential discoveries were the ob gene
aproduct Leptin (Zhang et al., 1994) and its
receptor (Tartaglia et al., 1995).
aRecently, nonmammalian genetic model
worganisms including nematodes (Caeno-
frhabditis elegans) and fruit flies (Dro-
rsophila melanogaster) have emerged as
fexcellent paradigms for research on the
iphysiology of obesity. A genome-scale
aRNAi screen in nematodes identified
wmore than 400 genes whose inactivation
uresults in either increased or decreased
(fat (Ashrafi et al., 2003). The identified
egenes included those involved in fat and
cholesterol metabolism; about 100 have r
mammalian orthologs that are known to l
efunction in lipid homeostasis. New can-
didate genes were also identified, in- f
scluding some that function in the central
nervous system. More than half of the u
nidentified genes have mammalian or-
thologs not previously implicated in fat e
ldeposition. This study underscores the
value of genetic analyses of nonmam- t
imalian model organisms in elucidatingCELL METABOLISM : MAY 2005he physiological basis of mammalian m
besity. d
Drosophila is emerging as another c
owerful system to study obesity. In m
lies, the masses and sheets of adipose n
issue that are distributed throughout the
rganism are collectively called the fat m
ody. Like mammalian adipocytes, insect a
at body cells constitute the animal’s ma- t
or energy reserve, accumulating TAG in m
ntracellular lipid droplets. This conserved f
unction suggests that the underlying ma- t
hinery and control mechanisms of fat g
torage are also evolutionarily con- m
erved. A regulated balance between li- g
ogenesis and lipolysis (TAG mobiliza- a
ion) maintains organismal fat storage to o
genetically determined set point. b
In this issue of Cell Metabolism, Grönke o
nd colleagues describe their genome- r
ide transcriptome analysis of fed and r
ood-deprived adult flies to identify nut- p
itionally regulated genes. The 223 dif- t
erentially regulated genes include genes e
nvolved in carbohydrate, amino acid, b
nd lipid catabolism, as well as 25% f
ith no assigned function. One gene m
pregulated upon starvation is brummer T
bmm), a homolog of human triacylglyc- c
rol lipase (ATGL). bmm is highly en- T
iched in fat body cells, as well as in the t
Tarval midgut and gastric caeca. Inter-
stingly, its expression in response to m
ood deprivation and refeeding post-
tarvation implicate brummer in the reg- s
slation of energy metabolism. Phyloge-
etic analysis indicates that Bmm is an t
svolutionarily conserved triacylglycerol
ipase, with a conserved region that con- t
lains a patatin-like domain (PLD) includ-
ng a serine hydrolase motif and a Brum- cigure 1. Fat stores represent the net balance between energy intake and energy expenditureer box. Grönke and coworkers further
emonstrate that recombinant Bmm can
leave TAG in vitro, whereas an enzy-
atically inactive catalytic mutant has
o activity.
To test whether bmm promotes fat
obilization in vivo, the authors gener-
ted bmm loss-of-function mutants. In-
erestingly, while embryos lacking both
aternal and zygotic bmm activity die,
lies lacking only zygotic Bmm lipase ac-
ivity develop normally but show pro-
ressive development of obesity as
easured by an increased amount of or-
anismal TAG relative to protein content,
s well as an increased size and number
f lipid storage droplets in single fat
ody cells. Conversely, overexpression
f bmm in fat body cells of fed flies, which
ecapitulates the starvation-induced up-
egulation of bmm transcription, de-
letes TAG content significantly. The lat-
er effects were not observed upon
xpression of an enzymatically inactive
mm transgene. Excessive fat storage in
lies lacking bmm function reduces the
edian life span by only 10%, and acute
AG mobilization is impaired but not
ompletely abolished in bmm mutants.
aken together, these results suggest
hat, like in mammals, mobilization of
AG storage in flies is controlled by
ore than one TAG lipase.
To further demonstrate the functional
imilarity between mammalian and Dro-
ophila TAG lipases, the authors showed
hat EGFP-tagged Bmm localizes at the
urface of lipid droplets. Finally, the au-
hors show that Bmm and the fly Peri-
ipin-like gene LSD-2 act antagonisti-
ally to regulate fat storage in vivo. This289
P R E V I E Wfinding is entirely consistent with what is n
bknown in the mammalian system, where
Perilipin has been shown to coat adipo-
gcyte lipid droplets and is postulated to
pmodulate the hydrolysis of triacylglycer-
tols. Perilipin-deficient mice are lean with
bconstitutive activation of adipocyte lipol-
uysis and resist high-fat diet-induced
fobesity (Tansey et al., 2001).
pThe identification and characterization
pof Bmm demonstrates the conservation
fof effectors controlling organismal fat
astorage in mammals and flies and em-
mphasizes the value of Drosophila for re-
vsearch in energy homeostasis. Although
smuch evidence suggests that abnormal-
gities in energy expenditure and regula-
ttion of fat storage contribute to the
a
development of obesity, the molecular
t
mechanisms that control these processes e
in humans are not well understood. Identi- t
fying the genetic causes of decreased e
energy expenditure and chronic imbal- t
ance of energy storage and developing o
therapies designed to specifically target
the same in obese humans have proved
Mdifficult. Work that integrates knowledge
from the genome project, along with a
studies in which candidate genes can be D
identified and manipulated and effects on H
whole-body energy homeostasis eval- H
uated (Grönke et al., 2005), is required 7
in order to identify the molecular mecha- B290Sisms responsible for regulating energy
alance.
AClearly, model organisms like C. ele- K
ans and Drosophila offer exciting pros- (
ects for obesity research. Because of
Bheir short generation time and ease of
Rreeding very large numbers of individ-
als, and the existence of powerful tools F
Jor genetic mapping and high-through-
ut methods for creation of mutants and F
henocopies, identification of genes in-
Fluencing specific phenotypes can be
ccomplished much more rapidly than in G
ice or humans. These experimental ad- P
Rantages are ideal for performing second
3ite modifier screens and should aid
reatly in the analysis of complex mul- K
igenic disorders. Validation of the mouse
Ond human homologs of the genes iden-
Bified from worm and fly studies will be an
xcellent strategy to accelerate the iden- T
Dification of molecular targets that may
Dventually produce safe and effective
(herapies for obesity and its related dis-
6rders.
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